business

business

U.S. FDA approval of INLEXZO™ (gemcitabine intravesical system) set to transform how certain bladder cancers are treated - Johnson & Johnson

Breaking Medical News: FDA Approves New Treatment for Bladder Cancer In a significant development in the field of oncology, Johnson & Johnson has announced that its newly developed treatment, INLEXZO (gemcitabine intravesical system), has been approved by the U.S. Food and Drug Administration (FDA). This approval marks an important

By Lau Chi Fung